RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Athira Pharma Stock

Athira Pharma Dividend 2024

Athira Pharma Dividend

0 USD

Athira Pharma Dividend yield

Ticker

ATHA

ISIN

US04746L1044

WKN

A2QCFW

How much dividend does Athira Pharma 2024 pay?

According to the latest status from October 2024, Athira Pharma paid a total of 0 USD per share in dividends within the last 12 months. With the current Athira Pharma price of 0 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Athira Pharma Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Athira Pharma Dividend Safe?

Athira Pharma has been increasing the dividend for 0 years.

Over the past 6 years, Athira Pharma has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Athira Pharma's Dividend Distributions

Athira Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Athira Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Athira Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Athira Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Athira Pharma Aktienanalyse

What does Athira Pharma do?

Athira Pharma Inc. is a biopharmaceutical company founded in 2011 and based in Seattle, USA. The company focuses on the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The strategy of Athira is to develop therapies for the treatment of diseases of the central nervous system and the regeneration of tissues that have been damaged by injuries or aging, based on RNA-based technologies. This work is carried out by an experienced team of scientists and executives. Athira's business model is based on the goal of developing innovative and personalized drug therapies to prevent, slow down, or specifically treat diseases. The company pursues an evidence-based approach called "patient-centered approach." Athira aims to understand the cause of certain diseases and develop targeted therapies that aim to treat that cause. Athira's research and development area consists of three units: 1. Neurology: This division focuses on the development of therapies for the treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis. The company has already developed a drug candidate that is in an extended phase I/II clinical trial and shows potential for the treatment of Alzheimer's dementia. 2. Regeneration: The regeneration division mainly deals with the regeneration of nerve cells and tissues in the body. This area has the potential to develop therapies for the treatment of spinal cord injuries and degenerative diseases of the body. 3. Platform technology: Athira's platform technologies are based on RNA interference technology, which aims to experimentally silence genes. The platform technology aims to identify and validate cell-specific RNA targets that can address a wide range of diseases. Athira specializes in the research and development of innovative therapies with the goal of defeating diseases and improving patients' health. The company has achieved significant successes in recent years, positioning itself as an important player in the industry. The market for therapies for the treatment of neurodegenerative diseases offers immense opportunities and potentials as these diseases are expected to increase in the future due to the aging population. Athira sees itself well positioned to take on the challenges in the industry and continue to develop innovative solutions for the treatment of diseases. Athira Pharma is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Athira Pharma stock

How much dividend does Athira Pharma pay?

Over the past 12 months, Athira Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athira Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Athira Pharma?

The current dividend yield of Athira Pharma is .

When does Athira Pharma pay dividends?

Athira Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Athira Pharma?

Athira Pharma paid dividends every year for the past 0 years.

What is the dividend of Athira Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Athira Pharma located?

Athira Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Athira Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Athira Pharma from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Athira Pharma pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Athira Pharma in the year 2023?

In the year 2023, Athira Pharma distributed 0 USD as dividends.

In which currency does Athira Pharma pay out the dividend?

The dividends of Athira Pharma are distributed in USD.

Andere Kennzahlen von Athira Pharma

Our stock analysis for Athira Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athira Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.